Vera Therapeutics, Inc. (VERA)

Vera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	92.65	45.68	43.46	79.67	53.65
Short-Term Investments	548.21	115.04	71.19	-	0.09
Cash & Short-Term Investments	640.85	160.72	114.65	79.67	53.74
Cash Growth	298.75%	40.18%	43.90%	48.26%	1564.29%
Other Receivables	3.77	0.51	-	-	0.05
Receivables	3.77	0.51	-	-	0.05
Prepaid Expenses	5.68	8.56	10.33	2.38	0.03
Restricted Cash	-	-	-	-	0.05
Other Current Assets	0.91	2.24	0.72	0.48	0.39
Total Current Assets	651.22	172.02	125.7	82.54	54.26
Property, Plant & Equipment	4.33	3.04	5.22	-	-
Long-Term Investments	-	-	0.06	0.87	-
Other Long-Term Assets	0.13	0.48	0.46	0.34	0.29
Total Assets	655.68	175.55	131.44	83.75	54.55
Accounts Payable	7.67	11.12	11.99	1.39	0.91
Accrued Expenses	16.22	8.75	10.96	5.93	0.54
Current Portion of Leases	1.48	2.44	2.65	-	-
Other Current Liabilities	-	-	-	0.38	0.96
Total Current Liabilities	25.37	22.3	25.6	7.69	2.41
Long-Term Debt	50.69	49.88	24.81	4.92	-
Long-Term Leases	2.47	1.4	3.83	-	-
Other Long-Term Liabilities	-	0.29	0.29	1.54	1.92
Total Liabilities	78.53	73.86	54.53	14.16	4.33
Common Stock	0.06	0.04	0.03	0.02	-
Additional Paid-In Capital	1,038	410.49	290.22	193.63	2.1
Retained Earnings	-461.25	-309.1	-213.11	-124.06	-91.45
Comprehensive Income & Other	0.39	0.25	-0.22	-	-
Total Common Equity	577.16	101.69	76.91	69.59	-89.35
Shareholders' Equity	577.16	101.69	76.91	69.59	50.23
Total Liabilities & Equity	655.68	175.55	131.44	83.75	54.55
Total Debt	54.64	53.71	31.29	4.92	-
Net Cash (Debt)	586.21	107.01	83.37	74.75	53.74
Net Cash Growth	447.82%	28.36%	11.53%	39.10%	1635.23%
Net Cash Per Share	10.60	2.51	3.14	5.56	167.96
Filing Date Shares Outstanding	63.75	54.45	44.26	27.05	0.36
Total Common Shares Outstanding	63.56	44.45	27.8	21.28	0.36
Working Capital	625.85	149.72	100.1	74.85	51.86
Book Value Per Share	9.08	2.29	2.77	3.27	-251.47
Tangible Book Value	577.16	101.69	76.91	69.59	-89.35
Tangible Book Value Per Share	9.08	2.29	2.77	3.27	-251.47

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q